We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00299637
Recruitment Status : Unknown
Verified March 2006 by Hadassah Medical Organization.
Recruitment status was:  Recruiting
First Posted : March 7, 2006
Last Update Posted : November 30, 2006
Sponsor:
Information provided by:

Study Description
Brief Summary:
This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

Condition or disease Phase
Chorioamnionitis Early Phase 1

Detailed Description:

This study will try to determine whether fetuses to mothers having clinical chorioamnionitis have changes in blood flow in middle cerebral artery.

MCA flow parameters will be evaluated during labor of women with and wthout chorioamnionitis


Study Design

Study Type : Observational
Estimated Enrollment : 34 participants
Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Prospective
Official Title: Changes in Blood Flow in MCA of Fetuses to Mothers Having Clinical Chorioamnionitis During Labor Comparing to Fetuses to Healthy Mothers.
Study Start Date : October 2006
Estimated Study Completion Date : December 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 45 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • women giving birth week 37-42
  • healthy
  • one fetus

Exclusion Criteria:

  • more than one fetus
  • IUGR
  • illness or damage to fetus
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00299637


Contacts
Contact: david mankuta, MD mankuta@yahoo.com

Locations
Israel
Haddasah Medical Organization Recruiting
Jerusalem, Israel, 12000
Contact: David Mankuta         
Principal Investigator: David Mankuta         
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Study Chair: David Mankuta, MD Hadassah Medical Organization
More Information

ClinicalTrials.gov Identifier: NCT00299637     History of Changes
Other Study ID Numbers: MCA chorioamnionitis HMO-CTIL
First Posted: March 7, 2006    Key Record Dates
Last Update Posted: November 30, 2006
Last Verified: March 2006

Additional relevant MeSH terms:
Chorioamnionitis
Fetal Diseases
Pregnancy Complications
Fetal Membranes, Premature Rupture
Obstetric Labor Complications
Placenta Diseases